| scholarly article | Q13442814 |
| P50 | author | Henry Daniell | Q30533568 |
| P2093 | author name string | S B Lee | |
| P O Wiebe | |||
| T Panchal | |||
| P2860 | cites work | Expression of cholera toxin B subunit oligomers in transgenic potato plants | Q54150448 |
| Oral immunization with a recombinant bacterial antigen produced in transgenic plants | Q54612499 | ||
| Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. | Q54696665 | ||
| Production of hepatitis B surface antigen in transgenic plants for oral immunization | Q57235165 | ||
| Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines | Q72271829 | ||
| Removal of antibiotic resistance genes from transgenic tobacco plastids | Q73150351 | ||
| Transformation and foreign gene expression in plants by microprojectile bombardment | Q73235746 | ||
| Sulfitolysis and thioredoxin‐dependent reduction reveal the presence of a structural disulfide bridge in spinach chloroplast fructose‐1,6‐bisphosphatase | Q74428608 | ||
| Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants | Q77472394 | ||
| Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco | Q78171079 | ||
| Technical Advance: Stable chloroplast transformation in potato: use of green fluorescent protein as a plastid marker | Q78216302 | ||
| Stable expression of a biodegradable protein-based polymer in tobacco chloroplasts | Q91514537 | ||
| Chloroplast ribosomes and protein synthesis | Q24634608 | ||
| Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi | Q31029896 | ||
| Plastid-expressed 5-enolpyruvylshikimate-3-phosphate synthase genes provide high level glyphosate tolerance in tobacco | Q32028970 | ||
| Plants for delivery of edible vaccines | Q33884980 | ||
| Engineering chloroplasts: an alternative site for foreign genes, proteins, reactions and products | Q33913433 | ||
| Why do chloroplasts and mitochondria contain so many copies of their genome? | Q34050314 | ||
| Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene | Q34067072 | ||
| Transgenic plants as factories for biopharmaceuticals | Q34076132 | ||
| Protein expression in plastids | Q34168052 | ||
| Novel approach in plastid transformation | Q34208094 | ||
| Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants | Q34240349 | ||
| Immunogenicity of transgenic plant-derived hepatitis B surface antigen | Q34437147 | ||
| Expression of hepatitis B surface antigen in transgenic plants | Q37337644 | ||
| Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit | Q37494112 | ||
| Regulation of chloroplast enzyme activities by thioredoxins: activation or relief from inhibition? | Q39439157 | ||
| Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems | Q40788029 | ||
| High-yield production of a human therapeutic protein in tobacco chloroplasts | Q40896181 | ||
| Containment of herbicide resistance through genetic engineering of the chloroplast genome | Q41096418 | ||
| Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals | Q42055155 | ||
| Antibiotic-free chloroplast genetic engineering - an environmentally friendly approach | Q43621614 | ||
| Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection | Q43639158 | ||
| Perspective: edible vaccines--a concept coming of age. | Q45171530 | ||
| A plant-derived edible vaccine against hepatitis B virus. | Q45746962 | ||
| Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato | Q47614578 | ||
| Computer-aided process analysis and economic evaluation for biosynthetic human insulin production-A case study | Q47864513 | ||
| Fluorescent antibiotic resistance marker for tracking plastid transformation in higher plants | Q47931679 | ||
| Characterization of replication origins flanking the 23S rRNA gene in tobacco chloroplast DNA. | Q48058109 | ||
| New tools for chloroplast genetic engineering | Q54080142 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholera | Q12090 |
| P304 | page(s) | 1001-1009 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Journal of Molecular Biology | Q925779 |
| P1476 | title | Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts | |
| P478 | volume | 311 |
| Q41839846 | A chloroplast transgenic approach to hyper-express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation |
| Q33385000 | A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). |
| Q33877026 | A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax |
| Q63886003 | A plant secretory signal peptide targets plastome-encoded recombinant proteins to the thylakoid membrane |
| Q47794492 | A protocol for expression of foreign genes in chloroplasts |
| Q51989941 | A strong constitutive gene expression system derived from ibAGP1 promoter and its transit peptide |
| Q50278167 | A synthetic gene increases TGFβ3 accumulation by 75-fold in tobacco chloroplasts enabling rapid purification and folding into a biologically active molecule |
| Q79406967 | Accumulation of rotavirus VP6 protein in chloroplasts of transplastomic tobacco is limited by protein stability |
| Q37562045 | Advances in chloroplast engineering |
| Q38662316 | Advances in molecular farming: key technologies, scaled up production and lead targets |
| Q35809251 | Advantageous features of plant-based systems for the development of HIV vaccines |
| Q46525035 | Approaches to achieve high-level heterologous protein production in plants |
| Q37853856 | Biopharmaceuticals from plants: a multitude of options for posttranslational modifications |
| Q36113211 | Breakthrough in chloroplast genetic engineering of agronomically important crops |
| Q84869398 | Can a plant-based vaccine treat hypertension? |
| Q38971193 | Challenges and perspectives in commercializing plastid transformation technology. |
| Q51421888 | Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, and translation |
| Q26747401 | Chloroplast genomes: diversity, evolution, and applications in genetic engineering |
| Q43152138 | Chloroplast transformation of rapeseed (Brassica napus) by particle bombardment of cotyledons |
| Q37023309 | Chloroplast vector systems for biotechnology applications |
| Q36690295 | Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties |
| Q40010728 | Chloroplast-derived enzyme cocktails hydrolyse lignocellulosic biomass and release fermentable sugars |
| Q37393185 | Chloroplast-derived vaccine antigens and biopharmaceuticals: expression, folding, assembly and functionality |
| Q36055964 | Chloroplast-derived vaccine antigens and other therapeutic proteins |
| Q33596284 | Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery |
| Q37859086 | Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. |
| Q37776719 | Chloroplasts as expression platforms for plant-produced vaccines |
| Q26748755 | Chloroplasts: state of research and practical applications of plastome sequencing |
| Q26782576 | Cholera Toxin Subunit B as Adjuvant--An Accelerator in Protective Immunity and a Break in Autoimmunity |
| Q35232735 | Cholera toxin B: one subunit with many pharmaceutical applications |
| Q49920855 | Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate |
| Q51183526 | Comparison of effectiveness of 5'-regulatory sequences in transplastomic tobacco chloroplasts. |
| Q34462622 | Complete chloroplast genome sequence of Gycine max and comparative analyses with other legume genomes |
| Q37173000 | Complete chloroplast genome sequences of Hordeum vulgare, Sorghum bicolor and Agrostis stolonifera, and comparative analyses with other grass genomes |
| Q83021985 | Complete chloroplast genome sequences of Solanum bulbocastanum, Solanum lycopersicum and comparative analyses with other Solanaceae genomes |
| Q28729990 | Complete chloroplast genome sequences of important oilseed crop Sesamum indicum L |
| Q22065315 | Complete plastid genome sequence of Daucus carota: implications for biotechnology and phylogeny of angiosperms |
| Q41808725 | Complete plastid genome sequence of the chickpea (Cicer arietinum) and the phylogenetic distribution of rps12 and clpP intron losses among legumes (Leguminosae). |
| Q50533663 | Contained and high-level production of recombinant protein in plant chloroplasts using a temporary immersion bioreactor. |
| Q37776724 | Current status of plant-made vaccines for veterinary purposes |
| Q90480090 | Cyanobacterial Production of Biopharmaceutical and Biotherapeutic Proteins |
| Q36316879 | Delivery of plant-derived vaccines |
| Q92259179 | Development of Systems for the Production of Plant-Derived Biopharmaceuticals |
| Q37776721 | Development of plant-based mucosal vaccines against widespread infectious diseases. |
| Q46827160 | Dual targeting of xylanase to chloroplasts and peroxisomes as a means to increase protein accumulation in plant cells |
| Q34735257 | Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. |
| Q36804213 | Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. |
| Q35909883 | Engineered chloroplast dsRNA silences cytochrome p450 monooxygenase, V-ATPase and chitin synthase genes in the insect gut and disrupts Helicoverpa armigera larval development and pupation |
| Q51406090 | Engineering cytoplasmic male sterility via the chloroplast genome by expression of {beta}-ketothiolase |
| Q34539630 | Engineering the plastid genome of higher plants |
| Q24568020 | Enhanced translation of a chloroplast-expressed RbcS gene restores small subunit levels and photosynthesis in nuclear RbcS antisense plants |
| Q42429984 | Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections |
| Q36349402 | Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop |
| Q28740786 | Expression of Trichoderma reesei β-mannanase in tobacco chloroplasts and its utilization in lignocellulosic woody biomass hydrolysis |
| Q52597279 | Expression of VGRNb-PE immunotoxin in transplastomic lettuce (Lactuca sativa L.). |
| Q42029623 | Expression of a Bacillus thuringiensis toxin (cry1Ab) gene in cabbage (Brassica oleracea L. var. capitata L.) chloroplasts confers high insecticidal efficacy against Plutella xylostella |
| Q45370503 | Expression of a Cholera Toxin B Subunit-Neutralizing Epitope of the Porcine Epidemic Diarrhea Virus Fusion Gene in Transgenic Lettuce (Lactuca sativa L.) |
| Q51755453 | Expression of a multi-epitope DPT fusion protein in transplastomic tobacco plants retains both antigenicity and immunogenicity of all three components of the functional oligomer |
| Q31029896 | Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi |
| Q37596275 | Expression of bacterial genes in transgenic tobacco: methods, applications and future prospects |
| Q81622100 | Expression of cholera toxin B subunit in transgenic rice endosperm |
| Q78529703 | Expression of cholera toxin B subunit in transgenic tomato plants |
| Q36990434 | Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice |
| Q34603242 | Expression of fungal cutinase and swollenin in tobacco chloroplasts reveals novel enzyme functions and/or substrates |
| Q51278409 | Expression of human BMP-2 gene in different tissues of tobacco plants |
| Q54512571 | Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. |
| Q45410974 | Expression of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice |
| Q46961052 | Expression of the recombinant bacterial outer surface protein A in tobacco chloroplasts leads to thylakoid localization and loss of photosynthesis |
| Q58468138 | F4 (K88) fimbrial adhesin FaeG expressed in alfalfa reduces F4+ enterotoxigenic Escherichia coli excretion in weaned piglets |
| Q37000665 | Field production and functional evaluation of chloroplast-derived interferon-alpha2b |
| Q38646698 | Genetic manipulations in crops: Challenges and opportunities. |
| Q51185720 | Genetic transformation of plastids of different Solanaceae species using tobacco cells as organelle hosts. |
| Q46542080 | Genetic transformation of the sugar beet plastome. |
| Q38992414 | Heterologous protein production in plant systems |
| Q57449904 | High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants |
| Q45422031 | High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts |
| Q43129804 | High-level expression of a human β-site APP cleaving enzyme in transgenic tobacco chloroplasts and its immunogenicity in mice |
| Q50705983 | High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. |
| Q82416184 | Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant |
| Q90667568 | Improved expression of porcine epidemic diarrhea antigen by fusion with cholera toxin B subunit and chloroplast transformation in Nicotiana tabacum |
| Q37776716 | In planta production of plant-derived and non-plant-derived adjuvants |
| Q43997827 | Induction of antigen-specific systemic and mucosal immune responses by feeding animals transgenic plants expressing the antigen |
| Q51059732 | Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification. |
| Q45875675 | Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A. |
| Q36445623 | Low cost delivery of proteins bioencapsulated in plant cells to human non-immune or immune modulatory cells. |
| Q36037525 | Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B. |
| Q34565122 | Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro |
| Q36344923 | Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide |
| Q45162649 | Metabolic engineering of the chloroplast genome using the Echerichia coli ubiC gene reveals that chorismate is a readily abundant plant precursor for p-hydroxybenzoic acid biosynthesis |
| Q34520477 | Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology |
| Q24629294 | Molecular strategies for gene containment in transgenic crops |
| Q28269565 | Motif analysis unveils the possible co-regulation of chloroplast genes and nuclear genes encoding chloroplast proteins |
| Q82345610 | Mucosal immunization using recombinant plant-based oral vaccines |
| Q24622960 | Multigene engineering: dawn of an exciting new era in biotechnology |
| Q44961613 | N-Glycosylation and N-Glycan Moieties of CTB Expressed in Rice Seeds |
| Q40143890 | N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines? |
| Q35003962 | N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential. |
| Q37182165 | Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function |
| Q28079063 | Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells |
| Q36083396 | Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice |
| Q33859520 | Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice |
| Q36640081 | Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells |
| Q36118497 | Oral hepatitis B vaccine candidates produced and delivered in plant material |
| Q41886182 | Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg |
| Q35907014 | Orally delivered malaria vaccines: not too hard to swallow |
| Q22065330 | Phylogenetic analyses of Vitis (Vitaceae) based on complete chloroplast genome sequences: effects of taxon sampling and phylogenetic methods on resolving relationships among rosids |
| Q44511176 | Phytoremediation of organomercurial compounds via chloroplast genetic engineering |
| Q36121986 | Phytoremediation of toxic trace elements in soil and water |
| Q37853859 | Plant Bioreactors for Pharmaceuticals |
| Q81447011 | Plant based HIV-1 vaccine candidate: Tat protein produced in spinach |
| Q51373188 | Plant biology: engineered male sterility |
| Q35121947 | Plant cell factories and mucosal vaccines |
| Q35623378 | Plant production systems for vaccines |
| Q59125274 | Plant-Based Vaccines: Production and Challenges |
| Q35348677 | Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells |
| Q37463784 | Plant-based oral vaccines: results of human trials |
| Q34194628 | Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge |
| Q35143262 | Plant-based vaccines |
| Q35779390 | Plant-derived vaccines against diarrhoeal diseases |
| Q36445550 | Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead |
| Q26783111 | Plant-made oral vaccines against human infectious diseases-Are we there yet? |
| Q37616370 | Plant-made vaccine antigens and biopharmaceuticals |
| Q30386732 | Plant-made vaccines for humans and animals. |
| Q36439033 | Plant-made vaccines: biotechnology and immunology in animal health |
| Q26783107 | Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents |
| Q34598066 | Plantibodies: applications, advantages and bottlenecks |
| Q37438883 | Plants as bioreactors for the production of vaccine antigens. |
| Q34018403 | Plants as bioreactors: Recent developments and emerging opportunities |
| Q38121856 | Plant‐derived pharmaceuticals for the developing world |
| Q84750549 | Plastid Proteostasis and Heterologous Protein Accumulation in Transplastomic Plants |
| Q57247534 | Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes |
| Q36282010 | Plastid genetic engineering in Solanaceae |
| Q36349439 | Plastid transformation in the monocotyledonous cereal crop, rice (Oryza sativa) and transmission of transgenes to their progeny. |
| Q45044393 | Plastid-expressed betaine aldehyde dehydrogenase gene in carrot cultured cells, roots, and leaves confers enhanced salt tolerance |
| Q26774629 | Plastids: The Green Frontiers for Vaccine Production |
| Q57443937 | Plastome Engineering: Basics Principles and Applications |
| Q37969791 | Potentials toward genetic engineering of drought-tolerant soybean |
| Q54449589 | Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine |
| Q42129955 | Production of Pentameric Cholera Toxin B Subunit in Escherichia coli |
| Q31082919 | Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco |
| Q54369243 | Production of biologically active human thioredoxin 1 protein in lettuce chloroplasts |
| Q90713910 | Production of tetravalent dengue virus envelope protein domain III based antigens in lettuce chloroplasts and immunologic analysis for future oral vaccine development |
| Q35547282 | Production of therapeutic antibodies in plants |
| Q35024858 | Progress towards commercialization of plastid transformation technology |
| Q24793809 | Rapid and reliable extraction of genomic DNA from various wild-type and transgenic plants |
| Q38085252 | Recent advances and safety issues of transgenic plant-derived vaccines |
| Q37290098 | Recent progress in the development of plant derived vaccines |
| Q36349444 | Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system |
| Q46431095 | Recombinant human acid beta-glucosidase stored in tobacco seed is stable, active and taken up by human fibroblasts |
| Q52712078 | Release of hormones from conjugates: chloroplast expression of β-glucosidase results in elevated phytohormone levels associated with significant increase in biomass and protection from aphids or whiteflies conferred by sucrose esters |
| Q31121342 | Release of proteins from intact chloroplasts induced by reactive oxygen species during biotic and abiotic stress |
| Q35865115 | Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination |
| Q46369340 | Selectable tolerance to herbicides by mutated acetolactate synthase genes integrated into the chloroplast genome of tobacco |
| Q40203743 | Stable chloroplast transformation in cabbage (Brassica oleracea L. var. capitata L.) by particle bombardment |
| Q30424547 | Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis |
| Q36327788 | Stable plastid transformation for high-level recombinant protein expression: promises and challenges. |
| Q84970027 | Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain |
| Q36349426 | Stable transformation of the cotton plastid genome and maternal inheritance of transgenes |
| Q90668573 | State of research in the field of the creation of plant vaccines for veterinary use |
| Q37812659 | Strategies for the plant‐based expression of dengue subunit vaccines |
| Q44065882 | Studies on the immunogenic potential of plant-expressed cholera toxin B subunit |
| Q34137024 | Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells |
| Q42167252 | T7 RNA polymerase-directed expression of an antibody fragment transgene in plastids causes a semi-lethal pale-green seedling phenotype |
| Q33826648 | The Assembly State between Magnetic Nanosensors and Their Targets Orchestrates Their Magnetic Relaxation Response |
| Q34677879 | The Induction of Recombinant Protein Bodies in Different Subcellular Compartments Reveals a Cryptic Plastid-Targeting Signal in the 27-kDa γ-Zein Sequence |
| Q21261975 | The complete chloroplast genome sequence of Citrus sinensis (L.) Osbeck var 'Ridge Pineapple': organization and phylogenetic relationships to other angiosperms |
| Q22065313 | The complete chloroplast genome sequence of Gossypium hirsutum: organization and phylogenetic relationships to other angiosperms |
| Q22065669 | The complete nucleotide sequence of the coffee (Coffea arabica L.) chloroplast genome: organization and implications for biotechnology and phylogenetic relationships amongst angiosperms |
| Q37393964 | The green vaccine: A global strategy to combat infectious and autoimmune diseases |
| Q34806017 | The potential of plant viral vectors and transgenic plants for subunit vaccine production |
| Q34267406 | The production of recombinant pharmaceutical proteins in plants. |
| Q58477212 | Tobacco plastidial thioredoxins as modulators of recombinant protein production in transgenic chloroplasts |
| Q37644601 | Tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
| Q26752474 | Transgene Expression in Microalgae-From Tools to Applications |
| Q35758721 | Transgene containment by maternal inheritance: effective or elusive? |
| Q90669923 | Transgenic plants for animal health: plant-made vaccine antigens for animal infectious disease control |
| Q36066053 | Transgenic plants in the biopharmaceutical market. |
| Q40347090 | Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer's disease mouse model |
| Q42058151 | Transient expression of hemagglutinin antigen from low pathogenic avian influenza A (H7N7) in Nicotiana benthamiana |
| Q47920285 | Translocation of aprotinin, a therapeutic protease inhibitor, into the thylakoid lumen of genetically engineered tobacco chloroplasts |
| Q33870122 | Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human Diseases |
Search more.